Lista de obras -

A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.

artículo científico publicado en 2008

Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs

artículo científico publicado en 2010

CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.

artículo científico publicado en 2011

Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.

artículo científico publicado en 2013

Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma

artículo científico publicado en 2013

Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992-2008)

scientific article published on 01 October 2011

Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*.

artículo científico publicado en 2011

Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

artículo científico publicado en 2009

Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.

artículo científico publicado en 2011

Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines.

artículo científico publicado en 2012

Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

artículo científico publicado en 2008

Immunohistochemical and histomorphometric evaluation of vascular distribution in intact canine cranial cruciate ligament.

artículo científico publicado en 2011

Immunohistochemical characterization of feline mast cell tumors.

artículo científico

Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.

artículo científico publicado en 2009

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine ⬇️

artículo científico publicado el 15 de mayo de 2003

Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008).

artículo científico publicado en 2011

Paraneoplastic hypertrophic osteopathy in 30 dogs

scientific article published on 14 March 2013

Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer‐bearing dogs ⬇️

artículo científico publicado el 24 de febrero de 2012

Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.

artículo científico publicado en 2011

Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU‐Induced Hepatopathy in Tumor‐Bearing Dogs ⬇️

artículo científico publicado el 20 de junio de 2011

Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.

artículo científico publicado en 2009

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

artículo científico publicado en 2011

Treatment of canine osseous tumors with photodynamic therapy: a pilot study.

artículo científico publicado en 2009

Vascular distribution in ruptured canine cranial cruciate ligament.

artículo científico publicado en 2011

Lista de obras de

A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.

Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs

CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.

Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.

Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma

Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992-2008)

Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*.

Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.

Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines.

Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

Immunohistochemical and histomorphometric evaluation of vascular distribution in intact canine cranial cruciate ligament.

Immunohistochemical characterization of feline mast cell tumors.

Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine ⬇️

Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008).

Paraneoplastic hypertrophic osteopathy in 30 dogs

Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer‐bearing dogs ⬇️

Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.

Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU‐Induced Hepatopathy in Tumor‐Bearing Dogs ⬇️

Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

Treatment of canine osseous tumors with photodynamic therapy: a pilot study.

Vascular distribution in ruptured canine cranial cruciate ligament.